Rebecca Liang
Stock Analyst at Bernstein
(4.36)
# 1,444
Out of 4,581 analysts
77
Total ratings
66.7%
Success rate
25.7%
Average return
Main Sectors:
Stocks Rated by Rebecca Liang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Rated: Hold | $130.00 | $92.70 | +40.24% | 18 | May 31, 2026 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Maintained: Buy | $44.00 → $47.00 | $32.64 | +44.00% | 8 | Apr 22, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $545.00 → $526.00 | $473.80 | +11.02% | 3 | Mar 26, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $412 | $327.21 | +25.91% | 19 | Mar 18, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $115.00 | $87.25 | +31.81% | 14 | Mar 12, 2026 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Maintained: Hold | $7.90 | $5.05 | +56.44% | 4 | Feb 9, 2026 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Hold | $10.70 | $8.49 | +26.03% | 7 | Feb 9, 2026 | |
| HKG: 9688 Zai Lab Limited | Maintained: Hold | $18.00 | $14.20 | +26.76% | 4 | Feb 9, 2026 |
Akeso, Inc.
May 31, 2026
Rated: Hold
Price Target: $130.00
Current: $92.70
Upside: +40.24%
Hansoh Pharmaceutical Group Company Limited
Apr 22, 2026
Maintained: Buy
Price Target: $44.00 → $47.00
Current: $32.64
Upside: +44.00%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $545.00 → $526.00
Current: $473.80
Upside: +11.02%
BeOne Medicines AG
Mar 18, 2026
Maintained: Buy
Price Target: $412
Current: $327.21
Upside: +25.91%
Innovent Biologics, Inc.
Mar 12, 2026
Maintained: Buy
Price Target: $115.00
Current: $87.25
Upside: +31.81%
Sino Biopharmaceutical Limited
Feb 9, 2026
Maintained: Hold
Price Target: $7.90
Current: $5.05
Upside: +56.44%
CSPC Pharmaceutical Group Limited
Feb 9, 2026
Maintained: Hold
Price Target: $10.70
Current: $8.49
Upside: +26.03%
Zai Lab Limited
Feb 9, 2026
Maintained: Hold
Price Target: $18.00
Current: $14.20
Upside: +26.76%